---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-005511"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2025-04-21T23:59:59+00:00"
generated_at: "2026-05-23T10:09:28.857926+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma raises ~$180k via convertible notes and board loan; conversion at deep discounts

## Summary
- $55k face convertible note issued at $50k (original issue discount) to GS Capital Partners; conversion price $5.00, drops to $2.50 if stock below $4 for 5 days.
- $79.2k convertible note issued with 15% one-time interest; conversion at 65% of lowest trading price after default (35% discount).
- $63k AUD loan from board member at 12% interest, due June 30, 2025; all proceeds for working capital.

## SEC filing metadata
- accession: 0001641172-25-005511
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2025-04-21T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000164117225005511/0001641172-25-005511-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000164117225005511/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-005511
- JSON: https://secwatch.observer/filing/0001641172-25-005511.json
- Plain text: https://secwatch.observer/filing/0001641172-25-005511.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.